Perbedaan Harga & Kinerja Astra Graphia Tbk (ASGR) vs Brigit Biofarmaka Teknologi Tbk. (OBAT)
Kinerja harga
Pergerakan harga dalam 24 jam terakhir
Statistik utama
Statistik utama
Perbedaan Astra Graphia Tbk dan Brigit Biofarmaka Teknologi Tbk.: Astra Graphia Tbk diperdagangkan di Rp1.745 (kapitalisasi pasar 2,23 T, volume 24 jam 6,2 jt), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp242 (kapitalisasi pasar 160,57 M, volume 24 jam 2,51 jt). Perbedaan utamanya: Astra Graphia Tbk jauh lebih besar — sekitar 13,9× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Astra Graphia Tbk lebih aktif diperdagangkan (6,2 jt vs 2,51 jt). Mana yang lebih baik tergantung tujuan investasimu.
| ASGR | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 2,23 T | 160,57 M |
Volume | 6,2 jt | 2,51 jt |
Lot | 61,98 rb | 25,09 rb |
Perputaran | 10,7 M | 636,74 jt |
Harga Rata-rata | 1.725,8 | 253,78 |
Nilai Transaksi | 10,7 M | 636,74 jt |
Harga Ekuilibrium Indikatif | 1.745 | 242 |
Volume Ekuilibrium Indikatif | 181 | 146 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Astra Graphia Tbk
PT Astra Graphia Tbk (the Company) was established in Indonesia on October 31, 1975 based on notarial deed No. 186 of Notary Kartini Muljadi, S.H. PT. Astra Graphia started its operations in 1975 as a member of Astra group (Xerox Division) and in 1976 Xerox division was incorporated as a separate entity under the name of PT Astra Graphia. The company core business is acting as sole distributor for several products in document and information services. The company is domestic investment.
Selengkapnya di halaman ASGR →Tentang Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →
